Yali is chief editor and publisher of the Journal of Commercial Biotechnology. He is also founder of and author of Building Biotechnology.

Washington, DC
Joined November 2008
The Intricate Journey of Drug Patents: From Filing to Expiry youtu.be/clsfpYQtwZE?si=cDCd… via @YouTube
26
Introducing : Empowering Access to Biopharmaceutical Drug Insights through AI Chat We are pleased to introduce , a groundbreaking platform that redefines the way professionals obtain concise, cited information on biopharmaceutica…lnkd.in/ewU5qPB7 DrugChatter.com
75
Introducing : Empowering Access to Biopharmaceutical Drug Insights through AI Chat We are pleased to introduce , a groundbreaking platform that redefines the way professionals obtain concise, cited information on biopharmaceutical…lnkd.in/eM7YwQaW DrugChatter.com
48
Introducing Drugchatter - Get concise, cited, information on biopharmaceutical drugs using AI GPT chat lnkd.in/enq3M7ku #ai
40
Counting R&D activity is a long shot from actual drug development. I haven't updated my study in a few years ( lnkd.in/eBxtJkFz ) but the vast majority of _approved_ drugs are invented by people in the US and Western Europe. lnkd.in/eZHM5_En
27
S05E01: Analyzing patents and litigation - Track litigation to anticipate early generic entry lnkd.in/eyK7x2dH